Now that Unitree has IPO'd, I'll drop what will likely be my last blog sometime next week. I'm not quite done writing just yet 🙃 It's ~3 months (~200h) of research condensed into ~70 minutes. Exploit is wormable, so if one G1 gets popped, it RCEs all other G1s in proximity
@kimocoder we're still talking that less than 10/s attempts, but if you have a good guess of what the password might be and are not in a rush, it's totally feasible :D
#bugbounty#infosec
Hey @yeswehack, is it normal for your support to completely ghost a researcher for 2 months during a mediation?🚨
I reported a Critical bug 6 months ago. After YWH poked the vendor about my underpayment,they retaliated by retroactively downgrading my CVSS🧵👇
@CristianPes lol thanks for the "legend" thingy, always weird receiving such compliments XD i'm getting there! i'm way luckier than many others, but it takes time
This is freaking huge: For the first time, a AI-assisted personalized mRNA cancer treatment has succeeded in a Phase 3 trial.
Moderna and Merck sequence each patient’s tumor and compare it with their healthy DNA. AI then helps identify which of the tumor’s mutations are most likely to trigger an immune response.
From those targets, Moderna produces an individual mRNA treatment encoding up to 34 neoantigens, The earlier Phase 2 trial followed patients with surgically removed high-risk melanoma for five years:
- 68.8% remained cancer-free, compared with 49.1% on Keytruda alone
- 49% lower risk of recurrence or death
- 59% lower risk of distant metastasis or death
Now the much larger Phase 3 trial involving 1,137 patients has also succeeded.
Absolutely incredible. Dario was right: cancer will be cured in just a few years!